EDGE MEDICAL-B: Yuanqian Gao Acquires Shares, Long Position Rises to 37.95%

HK Disclosure11-03

EDGE MEDICAL-B (02675) repurchased 85,500 H shares on the SEHK open market at an average of HKD 31.3779 per share on October 29, 2026, involving about HKD 2.68 million; as Yuanqian Gao controls one-third or more of the Company’s voting power, she is deemed under the SFO to be interested in the Company’s treasury shares, and her attributable long position therefore increased due to the issuer buyback (an on-exchange transaction matched on the SEHK open market rather than a direct secondary-market dealing by her).

Prior to the acquisition, Yuanqian Gao’s long position in EDGE MEDICAL-B was 124.31 million shares, representing 37.93%; following the acquisition, the holding changed to 124.39 million shares, with the long position ratio rising to 37.95%.

Source: Hong Kong Exchanges and Clearing Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment